Host Mike Moore recently interviewed Acarix CEO, Aamir Mahmood. The company's CADScor®System is an advanced acousticbased diagnostic aid to easily and quickly rule out significant coronary artery disease at point of care. As pointed out in this discussion, a number of clinical & economic value propositions exist for this technology, which will ultimately contribute to rapid adoption across multiple centers of care, starting with the Emergency Room.

Follow Mike Moore:

LinkedIn:   / michaeljeffreymoore  

Listen to The Bleeding Edge of Digital Health Podcast:

LinkedIn:   / thebleedingedgeofdigitalhealth  
Apple Podcasts: https://podcasts.apple.com/ph/podcast...
Spotify: https://open.spotify.com/show/23ggnkX...
Google: https://podcasts.google.com/feed/aHR0...
Amazon: https://www.amazon.com/BleedingEdge...